πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 125 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9326958

Compositions for treating chronic inflammation and inflammatory diseases

Infirst Healthcare Limited Β· Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9314465

Drug combinations and uses in treating a coughing condition

Infirst Healthcare Limited Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9308213

Solid solution compositions and use in chronic inflammation

Infirst Healthcare Limited Β· Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9308211

Drug combinations and uses in treating a coughing condition

Infirst Healthcare Limited Β· Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9271950

Compositions for treating chronic inflammation and inflammatory diseases

Infirst Healthcare Limited Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9266933

Polypeptides inhibiting neovascularization and uses thereof

SHANGHAI FIRST PEOPLE'S HOSPITAL Β· Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9265742

Compositions and methods for treating inflammatory pain

Infirst Healthcare Limited Β· Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9180113

Tocotrienol compositions

First Tech International Limited Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9161984

Formulations and methods of use for alpha connexin C-terminal (ACT) peptides

FIRSTSTRING RESEARCH, INC. Β· Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9161935

Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF the

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9115145

Tocotrienol derivatives and associated methods

First Tech International Limited Β· Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056127

Hydrogel composition based on co-polymer carrying multiple pendant sulphonic groups for us

FIRST WATER LIMITED Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9023795

Angiogenesis-inhibiting peptide and application thereof

SHANGHAI FIRST PEOPLE'S HOSPITAL Β· Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8969303

Tocotrienol esters

First Tech International Limited Β· Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8933031

Polypeptide inhibiting angiogenesis and application thereof

SHANGHAI FIRST PEOPLE'S HOSPITAL Β· Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8895536

Compositions and methods for treating chronic inflammation and inflammatory diseases

Infirst Healthcare Limited Β· Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8895537

Compositions and methods for treating cardiovascular diseases

Infirst Healthcare Limited Β· Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8846605

Formulations and methods of use for alpha connexin C-terminal (ACT) peptides

FIRSTRING RESEARCH, INC. Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8816071

Tocotrienol derivatives and associated methods

First Tech International Limited Β· Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8597948

Cloned biological material medical device and method thereof

FIRST PRINCIPLES, INC. Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8268786

Anti-cancer tocotrienol analogues and associated methods

First Tech International Limited Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 6951219

Treatment of hepatitis C using hyperthermia

First Circle Medical, Inc. Β· Granted Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6790980

Tannate compositions and methods of treatment

First Horizon Pharmaceutical Corporation Β· Granted Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6705556

Composition and method for inducing tolerance to viral infection in aquatic animals

First Republic Corporation of America Β· Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired